Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD
Clinical trial NCT04910152 · TERMINATED
Trial details
- NCT number
- NCT04910152
- Sponsor
- Hannah Choe, MD
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-19
- Primary completion
- 2023-09-28
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.